ATE484521T1 - Zyklische agonisten des crf - Google Patents

Zyklische agonisten des crf

Info

Publication number
ATE484521T1
ATE484521T1 AT98923787T AT98923787T ATE484521T1 AT E484521 T1 ATE484521 T1 AT E484521T1 AT 98923787 T AT98923787 T AT 98923787T AT 98923787 T AT98923787 T AT 98923787T AT E484521 T1 ATE484521 T1 AT E484521T1
Authority
AT
Austria
Prior art keywords
phe12
glu30
cyclo
nle21
lys33
Prior art date
Application number
AT98923787T
Other languages
English (en)
Inventor
Jean Rivier
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Application granted granted Critical
Publication of ATE484521T1 publication Critical patent/ATE484521T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5751—Corticotropin releasing factor [CRF] (Urotensin)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
AT98923787T 1997-05-30 1998-05-27 Zyklische agonisten des crf ATE484521T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/865,772 US5824771A (en) 1994-12-12 1997-05-30 Cyclic CRF agonists
PCT/US1998/010720 WO1998054222A1 (en) 1997-05-30 1998-05-27 Cyclic crf agonists

Publications (1)

Publication Number Publication Date
ATE484521T1 true ATE484521T1 (de) 2010-10-15

Family

ID=25346194

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98923787T ATE484521T1 (de) 1997-05-30 1998-05-27 Zyklische agonisten des crf

Country Status (7)

Country Link
US (1) US5824771A (de)
EP (1) EP0988320B1 (de)
JP (1) JP4166289B2 (de)
AT (1) ATE484521T1 (de)
AU (1) AU7599798A (de)
DE (1) DE69841938D1 (de)
WO (1) WO1998054222A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326463B1 (en) * 1994-12-12 2001-12-04 The Salk Institute For Biological Studies Cyclic CRF agonists
WO2002024732A2 (en) * 2000-09-22 2002-03-28 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
DE60231157D1 (de) * 2001-08-01 2009-03-26 Salk Inst For Biological Studi Crfr1 selektive liganden
US6936585B2 (en) * 2002-01-16 2005-08-30 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists
US6849600B2 (en) * 2002-03-25 2005-02-01 The Regents Of The University Of California, Berkeley Corticotropin-releasing hormone analogs
US20090035298A1 (en) * 2007-04-23 2009-02-05 Washington University In St. Louis Methods to treat alzheimer's disease or other amyloid beta accumulation associated disorders
EP2654772B1 (de) * 2010-12-22 2018-09-26 The Salk Institute for Biological Studies Zyklische peptide als crf-antagonisten
EP3379222B1 (de) 2017-03-22 2020-12-30 Methode Electronics Malta Ltd. Auf magnetoelastik basierte sensoranordnung
US11135882B2 (en) 2018-02-27 2021-10-05 Methode Electronics, Inc. Towing systems and methods using magnetic field sensing
US11221262B2 (en) 2018-02-27 2022-01-11 Methode Electronics, Inc. Towing systems and methods using magnetic field sensing
US11491832B2 (en) 2018-02-27 2022-11-08 Methode Electronics, Inc. Towing systems and methods using magnetic field sensing
US11084342B2 (en) 2018-02-27 2021-08-10 Methode Electronics, Inc. Towing systems and methods using magnetic field sensing
US11014417B2 (en) 2018-02-27 2021-05-25 Methode Electronics, Inc. Towing systems and methods using magnetic field sensing
WO2019168565A1 (en) 2018-02-27 2019-09-06 Methode Electronics,Inc. Towing systems and methods using magnetic field sensing
GB201816621D0 (en) 2018-10-12 2018-11-28 Univ Leuven Kath Prevention or treatment of adrenal insuffiency in critically ill patients

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632789A (en) * 1985-01-31 1986-12-30 Reid Philip L Gas humidification apparatus
US5109111A (en) * 1988-09-23 1992-04-28 The Salk Institute For Biological Studies CRF antagonists
CA1340964C (en) * 1988-09-30 2000-04-18 Jean E. F. Rivier Crf analogs
US5278146A (en) * 1988-09-30 1994-01-11 The Salk Institute For Biological Studies CRF analogs
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
US5245009A (en) * 1990-03-23 1993-09-14 The Salk Institute For Biological Studies CRF antagonists
US5235036A (en) * 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
US5493006A (en) * 1993-06-16 1996-02-20 The Salk Institute For Biological Studies Cyclic CRF analogs
US5663292A (en) * 1994-12-12 1997-09-02 The Salk Institute For Biological Studies Cyclic CRF analogs

Also Published As

Publication number Publication date
US5824771A (en) 1998-10-20
DE69841938D1 (de) 2010-11-25
WO1998054222A1 (en) 1998-12-03
AU7599798A (en) 1998-12-30
JP4166289B2 (ja) 2008-10-15
EP0988320B1 (de) 2010-10-13
JP2002511067A (ja) 2002-04-09
EP0988320A1 (de) 2000-03-29

Similar Documents

Publication Publication Date Title
DE69841938D1 (de) Zyklische agonisten des crf
WO1996019499A3 (en) Improved cyclic crf antagonists
Odermatt et al. Structural diversity and domain composition of a unique collagenous fragment (intima collagen) obtained from human placenta
Bailey et al. Partial characterization of a second basement membrane collagen in human placenta: evidence for the existence of two type IV collagen molecules
NO965411L (no) N-terminalt forlengede proteiner uttrykt i gjær
WO1996017924A3 (en) Novel hedgehog-derived polypeptides
WO1997028247A3 (fr) PROTEINES DE RESERVE DE PLANTES ENRICHIES EN ACIDES AMINES, NOTAMMENT η-ZEINE DE MAIS ENRICHIE EN LYSINE, PLANTES EXPRIMANT CES PROTEINES
DE3875538D1 (de) Aminoluciferine, verfahren zu deren herstellung und ihre verwendung.
YU50502A (sh) Postupak za prečišćavanje farmakološki aktivnih proteina pomoću katjonske izmenjivačke hromatografije
ES2054365T3 (es) Inhibicion de la via de la regla del n final en celulas vivas.
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
SiDLER et al. The complete amino-acid sequence of the α and β subunits of B-phycoerythrin from the rhodophytan alga Porphyridium cruentum
KR870004139A (ko) 인체 λ-인터페론의 생물학적 활성 유도체를 제조하는 방법
FI930626A (fi) Proteinstruktur hos vaexttoxingelonin
Canova-Davis et al. Characterization of chemically synthesized human relaxin by high-performance liquid chromatography
AU1503697A (en) Method for cleaving chimeric protein using processing enzyme
Meloun et al. Structure of N-terminal cyanogen bromide fragment of human plasma albumin
Van der Ouderaa et al. The molecular weight of the basic polypetide chain αB 2 of α-crystallin
Sasaki et al. Chemical studies on the isolated collagen-like and globular fragments of complement component C1q comparative studies on bovine and human C1q
PE47599A1 (es) Proteinas antiobesidad
Hackeng et al. Chemical synthesis of human protein S thrombin‐sensitive module and first epidermal growth factor module
PL316069A1 (en) Novel derivatives of biotin and method of obtaining them as well as pharmaceutic preparation and method of preparing same
Kimura et al. Total synthesis of human parathyroid hormone (1–84)
EP0147175A3 (de) Basische-Polypeptiden und Verfahren zu deren Herstellung
Berrini et al. Purification to homogeneity of bovine prolactin by high-performance ion-exchange chromatography

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties